UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on Lack of NT News Flow, Market Opportunity Visibility
UPDATE: Leerink Swann Raises PT on The Medicines Company Following Analyst Meeting
Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks
Leerink Swann Raises Inspire Pharmaceuticals (ISPH) Price Target To $10